Anbio Biotechnology (NNNN) Total Liabilities (2023 - 2025)

Anbio Biotechnology (NNNN) has 3 years of Total Liabilities data on file, last reported at $87836.0 in Q4 2025.

• On a quarterly basis, Total Liabilities fell 94.92% year-over-year to $87836.0 in Q4 2025; TTM through Dec 2025 was $87836.0, a 94.92% decrease from a year earlier, with the FY2025 full-year figure at $87836.0, down 94.92% from the prior year.
• Total Liabilities for Q4 2025 stood at $87836.0, down from $131.1 billion in the prior quarter.
• Over the last five years, Total Liabilities for NNNN reached as high as $131.1 billion in Q2 2025 and fell as low as $87836.0 in Q4 2025.
• Historically, Total Liabilities has averaged $32.8 billion across 3 years, with a median of $1.4 million in 2023.
• Across the five-year window, Total Liabilities jumped 74.23% in 2024 and tumbled 94.92% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $993060.0 in 2023, then soared by 74.23% to $1.7 million in 2024, then tumbled by 94.92% to $87836.0 in 2025.
• Per Business Quant data, the three most recent Total Liabilities figures were $87836.0 in Q4 2025, $131.1 billion in Q2 2025, and $1.7 million in Q4 2024.